CPAP compliance in patients with obstructive sleep apnea syndrome

Obstructive sleep apnea syndrome (OSAS) is characterized by repeated cessations of breathing during sleep. Major symptoms of this disease are excessive daytime sleepiness, snoring, and witnessed apnea. Most of the patients are treated with CPAP. In this study, we aimed to evaluate the factors affect...

Full description

Saved in:
Bibliographic Details
Published in:Sleep & breathing 2008-11, Vol.12 (4), p.365-367
Main Authors: Yetkin, Ozkan, Kunter, Erdogan, Gunen, Hakan
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Continuous Positive Airway Pressure - psychology
Dentistry
Disorders of Excessive Somnolence - psychology
Disorders of Excessive Somnolence - therapy
Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes
Female
Fundamental and applied biological sciences. Psychology
Humans
Internal Medicine
Male
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Nervous system (semeiology, syndromes)
Neurology
Original Article
Otorhinolaryngology
Patient Compliance - psychology
Pediatrics
Pneumology/Respiratory System
Polysomnography
Prospective Studies
Sleep apnea
Sleep Apnea, Obstructive - psychology
Sleep Apnea, Obstructive - therapy
Sleep disorders
Sleep. Vigilance
Vertebrates: nervous system and sense organs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obstructive sleep apnea syndrome (OSAS) is characterized by repeated cessations of breathing during sleep. Major symptoms of this disease are excessive daytime sleepiness, snoring, and witnessed apnea. Most of the patients are treated with CPAP. In this study, we aimed to evaluate the factors affecting adherence to the CPAP treatment. Seventy-one patients were enrolled to this study. Patients were divided into three groups according to CPAP usage. Group I consisted of patients who had never used CPAP, group II consisted of patients who had used CPAP occasionally, and group-III patients had used CPAP treatment regularly. Group-III patients had higher apnea–hypopnea index (AHI) than groups I and II (respectively, 56.6 ± 27.7, 26.3 ± 7.5, and 32.3 ± 7.06; p  
ISSN:1520-9512
1522-1709
DOI:10.1007/s11325-008-0188-4